Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Fabino Life Sciences IPO and Vivo Collaboration IPO.
Fabino Life Sciences IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Vivo Collaboration IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| Fabino Life Sciences IPO | Vivo Collaboration IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Aryaman Financial Services Limited | Sarthi Capital Advisors Private Limited |
| Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Fabino Life Sciences IPO is up to ₹3.24 Cr whereas the issue size of the Vivo Collaboration IPO is up to ₹4.40 Cr. The final issue price of Fabino Life Sciences IPO is ₹36.00 per share and of Vivo Collaboration IPO is ₹82.00 per share.
| Fabino Life Sciences IPO | Vivo Collaboration IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹36.00 per share | ₹82.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1600 shares |
| Fresh Issue Size | 9,00,000 shares | 5,36,000 shares |
| Fresh Issue Size (Amount) | up to ₹3.24 Cr | up to ₹4.40 Cr |
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 9,00,000 shares | 5,36,000 shares |
| Issue Size Total (Amount) | up to ₹3.24 Cr | up to ₹4.40 Cr |
Fabino Life Sciences IPO opens on Dec 31, 2021, while Vivo Collaboration IPO opens on Dec 20, 2021. The closing date of Fabino Life Sciences IPO and Vivo Collaboration IPO is Jan 05, 2022, and Dec 23, 2021, respectively.
| Fabino Life Sciences IPO | Vivo Collaboration IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Dec 31, 2021 | Dec 20, 2021 |
| Issue Close | Jan 05, 2022 | Dec 23, 2021 |
| Basis Of Allotment (Tentative) | Jan 10, 2022 | |
| Initiation of Refunds (Tentative) | Jan 11, 2022 | |
| Credit of Share (Tentative) | Jan 12, 2022 | |
| Listing date (Tentative) | Jan 13, 2022 | |
| Anchor Lockin End date 1 | Feb 09, 2022 | |
| Anchor Lockin End date 2 | Apr 10, 2022 |
Fabino Life Sciences IPO P/E ratio is 133, as compared to Vivo Collaboration IPO P/E ratio of .
| Fabino Life Sciences IPO | Vivo Collaboration IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.43% | 100.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 56.82% | 73.40% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 133 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7.56 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Fabino Life Sciences IPO retail investors (RII) are offered 4,26,000 shares while in Vivo Collaboration IPO retail investors are offered 4,26,000 shares. Qualified institutional buyers (QIB) are offered in Fabino Life Sciences IPO and in Vivo Collaboration IPO.
| Fabino Life Sciences IPO | Vivo Collaboration IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 48,000 shares | 27,200 shares |
| QIB | ||
| NII | 4,26,000 shares | 2,54,400 shares |
| RII | 4,26,000 shares | 2,54,400 shares |
| Employee | ||
| Others | ||
| Total | 8,52,000 shares | 5,08,800 shares |
Fabino Life Sciences IPO subscribed 6.93x in total, whereas Vivo Collaboration IPO subscribed 282.97x.
| Fabino Life Sciences IPO | Vivo Collaboration IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.49x | 292.86x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 10.36x | 273.08x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 6.93x | 282.97x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
